This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1 KA Youdim & JA Joseph (2001) A possible emerging role of phytochemicals in improving age-related neurological dysfunctions: a multiplicity of effects. Free Radic Biol Med 30, 583–594.
2 KA Youdim , JP Spencer , H Schroeter & C Rice-Evans (2002) Dietary flavonoids as potential neuroprotectants. Biol Chem 383, 503–519.
3 RL Galli , B Shukitt-Hale , KA Youdim & JA Joseph (2002) Fruit polyphenolics and brain aging: nutritional interventions targeting age-related neuronal and behavioral deficits. Ann N Y Acad Sci 959, 128–132.
4 K Unno , F Takabayashi , T Kishido & N Oku (2004) Suppressive effect of green tea catechins on morphologic and functional regression of the brain in aged mice with accelerated senescence (SAMP10). Exp Gerontol 39, 1027–1034.
7 Y Wang , L Wang , J Wu & J Cai (2006) The in vivo synaptic plasticity mechanism of EGb 761-induced enhancement of spatial learning and memory in aged rats. Br J Pharmacol 148, 147–153.
8 O Inanami , Y Watanabe , B Syuto , M Nakano , M Tsuji & M Kuwabara (1998) Oral administration of ( − )catechin protects against ischemia-reperfusion-induced neuronal death in the gerbil. Free Radic Res 29, 359–365.
9 Y Luo , JV Smith , V Paramasivam , A Burdick , KJ Curry , JP Buford , I Khan , WJ Netzer , H Xu & P Butko (2002) Inhibition of amyloid-beta aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761. Proc Natl Acad Sci U S A 99, 12197–12202.
10 S Bastianetto , WH Zheng & R Quirion (2000) The Ginkgo biloba extract (EGb 761) protects and rescues hippocampal cells against nitric oxide-induced toxicity: involvement of its flavonoid constituents and protein kinase C. J Neurochem 74, 2268–2277.
12 KP Datla , M Christidou , WW Widmer , HK Rooprai & DT Dexter (2001) Tissue distribution and neuroprotective effects of citrus flavonoid tangeretin in a rat model of Parkinson's disease. Neuroreport 12, 3871–3875.
13 CA Rice-Evans , NJ Miller & G Paganga (1996) Structure–antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med 20, 933–956.
14 RJ Williams , JPE Spencer & C Rice-Evans (2004) Flavonoids: antioxidants or signalling molecules? Free Radic Biol Med 36, 838–849.
15 JPE Spencer , C Rice-Evans & RJ Williams (2003) Modulation of pro-survival Akt/PKB and ERK1/2 signalling cascades by quercetin and its in vivo metabolites underlie their action on neuronal viability. J Biol Chem 278, 34783–34793.
16 H Schroeter , C Boyd , JPE Spencer , RJ Williams , E Cadenas & C Rice-Evans (2002) MAPK signaling in neurodegeneration: influences of flavonoids and of nitric oxide. Neurobiol Aging 23, 861–880.
18 C Rice-Evans (2001) Flavonoid antioxidants. Curr Med Chem 8, 797–807.
19 C Rice-Evans (1995) Plant polyphenols: free radical scavengers or chain-breaking antioxidants? Biochem Soc Symp 61, 103–116.
20 JPE Spencer , H Schroeter , AR Rechner & C Rice-Evans (2001) Bioavailability of flavan-3-ols and procyanidins: gastrointestinal tract influences and their relevance to bioactive forms in vivo. Antioxid Redox Signal 3, 1023–1039.
25 JPE Spencer , G Chowrimootoo , R Choudhury , ES Debnam , SK Srai & C Rice-Evans (1999) The small intestine can both absorb and glucuronidate luminal flavonoids. FEBS Lett 458, 224–230.
27 JPE Spencer , GG Kuhnle , RJ Williams & C Rice-Evans (2003) Intracellular metabolism and bioactivity of quercetin and its in vivo metabolites. Biochem J 372, 173–181.
28 JPE Spencer , H Schroeter , AJ Crossthwaithe , G Kuhnle , RJ Williams & C Rice-Evans (2001) Contrasting influences of glucuronidation and O-methylation of epicatechin on hydrogen peroxide-induced cell death in neurons and fibroblasts. Free Radic Biol Med 31, 1139–1146.
29 Y Miyake , K Shimoi , S Kumazawa , K Yamamoto , N Kinae & T Osawa (2000) Identification and antioxidant activity of flavonoid metabolites in plasma and urine of eriocitrin-treated rats. J Agric Food Chem 48, 3217–3224.
30 J Terao , S Yamaguchi , M Shirai , M Miyoshi , JH Moon , S Oshima , T Inakuma , T Tsushida & Y Kato (2001) Protection by quercetin and quercetin 3-O-beta-d-glucuronide of peroxynitrite-induced antioxidant consumption in human plasma low-density lipoprotein. Free Radic Res 35, 925–931.
31 M Shirai , JH Moon , T Tsushida & J Terao (2001) Inhibitory effect of a quercetin metabolite, quercetin 3-O-beta-d-glucuronide, on lipid peroxidation in liposomal membranes. J Agric Food Chem 49, 5602–5608.
32 N Yamamoto , JH Moon , T Tsushida , A Nagao & J Terao (1999) Inhibitory effect of quercetin metabolites and their related derivatives on copper ion-induced lipid peroxidation in human low-density lipoprotein. Arch Biochem Biophys 372, 347–354.
33 EL da Silva , MK Piskula , N Yamamoto , JH Moon & J Terao (1998) Quercetin metabolites inhibit copper ion-induced lipid peroxidation in rat plasma. FEBS Lett 430, 405–408.
34 NJ Abbott (2002) Astrocyte–endothelial interactions and blood–brain barrier permeability. J Anat 200, 629–638.
35 KA Youdim , MS Dobbie , G Kuhnle , AR Proteggente , NJ Abbott & C Rice-Evans (2003) Interaction between flavonoids and the blood–brain barrier: in vitro studies. J Neurochem 85, 180–192.
36 KA Youdim , B Shukitt-Hale & JA Joseph (2004) Flavonoids and the brain: interactions at the blood–brain barrier and their physiological effects on the central nervous system. Free Radic Biol Med 37, 1683–1693.
37 KA Youdim , MZ Qaiser , DJ Begley , CA Rice-Evans & NJ Abbott (2004) Flavonoid permeability across an in situ model of the blood–brain barrier. Free Radic Biol Med 36, 592–604.
39 B Sperker , JT Backman & HK Kroemer (1997) The role of beta-glucuronidase in drug disposition and drug targeting in humans. Clin Pharmacokinet 33, 18–31.
40 HK Kroemer & U Klotz (1992) Glucuronidation of drugs. A re-evaluation of the pharmacological significance of the conjugates and modulating factors. Clin Pharmacokinet 23, 292–310.
41 JH Lin & M Yamazaki (2003) Role of P-glycoprotein in pharmacokinetics: clinical implications. Clin Pharmacokinet 42, 59–98.
42 M Suganuma , S Okabe , M Oniyama , Y Tada , H Ito & H Fujiki (1998) Wide distribution of [3H]( − )-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. Carcinogenesis 19, 1771–1776.
43 MM Abd El Mohsen , G Kuhnle , AR Rechner , H Schroeter , S Rose , P Jenner & CA Rice-Evans (2002) Uptake and metabolism of epicatechin and its access to the brain after oral ingestion. Free Radic Biol Med 33, 1693–1702.
44 S Talavera , C Felgines , O Texier , C Besson , A Gil-Izquierdo , JL Lamaison & C Remesy (2005) Anthocyanin metabolism in rats and their distribution to digestive area, kidney, and brain. J Agric Food Chem 53, 3902–3908.
46 C Andres-Lacueva , B Shukitt-Hale , RL Galli , O Jauregui , RM Lamuela-Raventos & JA Joseph (2005) Anthocyanins in aged blueberry-fed rats are found centrally and may enhance memory. Nutr Neurosci 8, 111–120.
47 B Halliwell , K Zhao & M Whiteman (2000) The gastrointestinal tract: a major site of antioxidant action? Free Radic Res 33, 819–830.
50 G Casadesus , B Shukitt-Hale , HM Stellwagen , X Zhu , HG Lee , MA Smith & JA Joseph (2004) Modulation of hippocampal plasticity and cognitive behavior by short-term blueberry supplementation in aged rats. Nutr Neurosci 7, 309–316.
51 B Shukitt-Hale , DE Smith , M Meydani & JA Joseph (1999) The effects of dietary antioxidants on psychomotor performance in aged mice. Exp Gerontol 34, 797–808.
53 P Goyarzu , DH Malin , FC Lau , (2004) Blueberry supplemented diet: effects on object recognition memory and nuclear factor-kappa B levels in aged rats. Nutr Neurosci 7, 75–83.
54 JA Joseph , NA Denisova , G Arendash , M Gordon , D Diamond , B Shukitt-Hale & D Morgan (2003) Blueberry supplementation enhances signaling and prevents behavioral deficits in an Alzheimer disease model. Nutr Neurosci 6, 153–162.
55 MR Ramirez , I Izquierdo , RM do Carmo Bassols , JA Zuanazzi , D Barros & AT Henriques (2005) Effect of lyophilised Vaccinium berries on memory, anxiety and locomotion in adult rats. Pharmacol Res 52, 457–462.
56 H Schroeter , C Heiss , J Balzer , P Kleinbongard , CL Keen , NK Hollenberg , H Sies , C Kwik-Uribe , HH Schmitz & M Kelm (2006) ( − )-Epicatechin mediates beneficial effects of flavanol-rich cocoa on vascular function in humans. Proc Natl Acad Sci U S A 103, 1024–1029.
57 ST Francis , K Head , PG Morris & IA Macdonald (2006) The effect of flavanol-rich cocoa on the fMRI response to a cognitive task in healthy young people. J Cardiovasc Pharmacol 47, Suppl. 2, S215–S220.
58 ND Fisher , FA Sorond & NK Hollenberg (2006) Cocoa flavanols and brain perfusion. J Cardiovasc Pharmacol 47, Suppl. 2, S210–S214.
59 FH Gage (2000) Mammalian neural stem cells. Science 287, 1433–1438.
60 TD Palmer , AR Willhoite & FH Gage (2000) Vascular niche for adult hippocampal neurogenesis. J Comp Neurol 425, 479–494.
61 KM Harris & SB Kater (1994) Dendritic spines: cellular specializations imparting both stability and flexibility to synaptic function. Annu Rev Neurosci 17, 341–371.
62 TJ Carew (1996) Molecular enhancement of memory formation. Neuron 16, 5–8.
63 KC Martin , M Barad & ER Kandel (2000) Local protein synthesis and its role in synapse-specific plasticity. Curr Opin Neurobiol 10, 587–592.
64 RJ Kelleher III, A Govindarajan & S Tonegawa (2004) Translational regulatory mechanisms in persistent forms of synaptic plasticity. Neuron 44, 59–73.
65 S Impey , SR McCorkle , H Cha-Molstad , JM Dwyer , GS Yochum , JM Boss , S McWeeney , JJ Dunn , G Mandel & RH Goodman (2004) Defining the CREB regulon: a genome-wide analysis of transcription factor regulatory regions. Cell 119, 1041–1054.
66 A Barco , CH Bailey & ER Kandel (2006) Common molecular mechanisms in explicit and implicit memory. J Neurochem 97, 1520–1533.
67 R Bourtchuladze , B Frenguelli , J Blendy , D Cioffi , G Schutz & AJ Silva (1994) Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein. Cell 79, 59–68.
68 T Tully , R Bourtchouladze , R Scott & J Tallman (2003) Targeting the CREB pathway for memory enhancers. Nat Rev Drug Discov 2, 267–277.
69 TA Pham , S Impey , DR Storm & MP Stryker (1999) CRE-mediated gene transcription in neocortical neuronal plasticity during the developmental critical period. Neuron 22, 63–72.
70 S Impey , DM Smith , K Obrietan , R Donahue , C Wade & DR Storm (1998) Stimulation of cAMP response element (CRE)-mediated transcription during contextual learning. Nat Neurosci 1, 595–601.
71 S Impey , M Mark , EC Villacres , S Poser , C Chavkin & DR Storm (1996) Induction of CRE-mediated gene expression by stimuli that generate long-lasting LTP in area CA1 of the hippocampus. Neuron 16, 973–982.
72 H Schroeter , JP Spencer , C Rice-Evans & RJ Williams (2001) Flavonoids protect neurons from oxidized low-density-lipoprotein-induced apoptosis involving c-Jun N-terminal kinase (JNK), c-Jun and caspase-3. Biochem J 358, 547–557.
73 H Schroeter , P Bahia , JPE Spencer , O Sheppard , M Rattray , C Rice-Evans & RJ Williams (2007) ( − )-Epicatechin stimulates ERK-dependent cyclic AMP response element activity and upregulates GLUR2 in cortical neurons J Neurochem 101, 1596–1606..
74 P Maher , T Akaishi & K Abe (2006) Flavonoid fisetin promotes ERK-dependent long-term potentiation and enhances memory. Proc Natl Acad Sci U S A 103, 16568–16573.
75 MD Conkright , E Guzman , L Flechner , AI Su , JB Hogenesch & M Montminy (2003) Genome-wide analysis of CREB target genes reveals a core promoter requirement for cAMP responsiveness. Mol Cell 11, 1101–1108.
76 X Tao , S Finkbeiner , DB Arnold , AJ Shaywitz & ME Greenberg (1998) Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron 20, 709–726.
77 PB Shieh , SC Hu , K Bobb , T Timmusk & A Ghosh (1998) Identification of a signaling pathway involved in calcium regulation of BDNF expression. Neuron 20, 727–740.
78 CR Bramham & E Messaoudi (2005) BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis. Prog Neurobiol 76, 99–125.
79 SL Patterson , LM Grover , PA Schwartzkroin & M Bothwell (1992) Neurotrophin expression in rat hippocampal slices: a stimulus paradigm inducing LTP in CA1 evokes increases in BDNF and NT-3 mRNAs. Neuron 9, 1081–1088.
80 K Thomas & A Davies (2005) Neurotrophins: a ticket to ride for BDNF. Curr Biol 15, R262–R264.
81 S Peng , J Wuu , EJ Mufson & M Fahnestock (2005) Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease. J Neurochem 93, 1412–1421.
82 B Michalski & M Fahnestock (2003) Pro-brain-derived neurotrophic factor is decreased in parietal cortex in Alzheimer's disease. Brain Res Mol Brain Res 111, 148–154.
83 MF Egan , M Kojima , JH Callicott , (2003) The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112, 257–269.
84 S Linnarsson , A Bjorklund & P Ernfors (1997) Learning deficit in BDNF mutant mice. Eur J Neurosci 9, 2581–2587.
85 JS Mu , WP Li , ZB Yao & XF Zhou (1999) Deprivation of endogenous brain-derived neurotrophic factor results in impairment of spatial learning and memory in adult rats. Brain Res 835, 259–265.
86 L Minichiello , M Korte , D Wolfer , R Kuhn , K Unsicker , V Cestari , C Rossi-Arnaud , HP Lipp , T Bonhoeffer & R Klein (1999) Essential role for TrkB receptors in hippocampus-mediated learning. Neuron 24, 401–414.
87 S Wullschleger , R Loewith & MN Hall (2006) TOR signaling in growth and metabolism. Cell 124, 471–484.
88 GM Schratt , EA Nigh , WG Chen , L Hu & ME Greenberg (2004) BDNF regulates the translation of a select group of mRNAs by a mammalian target of rapamycin-phosphatidylinositol 3-kinase-dependent pathway during neuronal development. J Neurosci 24, 7366–7377.
89 Y Yin , GM Edelman & PW Vanderklish (2002) The brain-derived neurotrophic factor enhances synthesis of Arc in synaptoneurosomes. Proc Natl Acad Sci U S A 99, 2368–2373.
91 J Soule , E Messaoudi & CR Bramham (2006) Brain-derived neurotrophic factor and control of synaptic consolidation in the adult brain. Biochem Soc Trans 34, 600–604.
92 GL Lyford , K Yamagata , WE Kaufmann , CA Barnes , LK Sanders , NG Copeland , DJ Gilbert , NA Jenkins , AA Lanahan & PF Worley (1995) Arc, a growth factor and activity-regulated gene, encodes a novel cytoskeleton-associated protein that is enriched in neuronal dendrites. Neuron 14, 433–445.
94 EC Hirsch , S Hunot & A Hartmann (2005) Neuroinflammatory processes in Parkinson's disease. Parkinsonism Relat Disord 11, Suppl. 1, S9–S15.
95 EG McGeer & PL McGeer (2003) Inflammatory processes in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 27, 741–749.
96 Z Zheng , JE Lee & MA Yenari (2003) Stroke: molecular mechanisms and potential targets for treatment. Curr Mol Med 3, 361–372.
97 D Casper , U Yaparpalvi , N Rempel & P Werner (2000) Ibuprofen protects dopaminergic neurons against glutamate toxicity in vitro. Neurosci Lett 289, 201–204.
98 H Chen , SM Zhang , MA Hernan , MA Schwarzschild , WC Willett , GA Colditz , FE Speizer & A Ascherio (2003) Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease. Arch Neurol 60, 1059–1064.
99 EG McGeer & PL McGeer (1997) The role of the immune system in neurodegenerative disorders. Mov Disord 12, 855–858.
100 M Vila , V Jackson-Lewis , C Guegan , DC Wu , P Teismann , DK Choi , K Tieu & S Przedborski (2001) The role of glial cells in Parkinson's disease. Curr Opin Neurol 14, 483–489.
101 YS Kim & TH Joh (2006) Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease. Exp Mol Med 38, 333–347.
102 SM Allan & NJ Rothwell (2003) Inflammation in central nervous system injury. Philos Trans R Soc Lond B Biol Sci 358, 1669–1677.
103 VC Stewart & SJ Heales (2003) Nitric oxide-induced mitochondrial dysfunction: implications for neurodegeneration. Free Radic Biol Med 34, 287–303.
104 S Moncada & JP Bolanos (2006) Nitric oxide, cell bioenergetics and neurodegeneration. J Neurochem 97, 1676–1689.
105 N Kozuka , R Itofusa , Y Kudo & M Morita (2005) Lipopolysaccharide and proinflammatory cytokines require different astrocyte states to induce nitric oxide production. J Neurosci Res 82, 717–728.
106 A Bal-Price , A Matthias & GC Brown (2002) Stimulation of the NADPH oxidase in activated rat microglia removes nitric oxide but induces peroxynitrite production. J Neurochem 80, 73–80.
107 BL Fiebich , K Lieb , S Engels & M Heinrich (2002) Inhibition of LPS-induced p42/44 MAP kinase activation and iNOS/NO synthesis by parthenolide in rat primary microglial cells. J Neuroimmunol 132, 18–24.
109 JS Marcus , SL Karackattu , MA Fleegal & C Sumners (2003) Cytokine-stimulated inducible nitric oxide synthase expression in astroglia: role of Erk mitogen-activated protein kinase and NF-kappaB. Glia 41, 152–160.
110 S Pawate & NR Bhat (2006) C-Jun N-terminal kinase (JNK) regulation of iNOS expression in glial cells: predominant role of JNK1 isoform. Antioxid Redox Signal 8, 903–909.
111 R Li , YG Huang , D Fang & WD Le (2004) ( − )-Epigallocatechin gallate inhibits lipopolysaccharide-induced microglial activation and protects against inflammation-mediated dopaminergic neuronal injury. J Neurosci Res 78, 723–731.
112 Q Huang , LJ Wu , S Tashiro , HY Gao , S Onodera & T Ikejima (2005) (+)-Catechin, an ingredient of green tea, protects murine microglia from oxidative stress-induced DNA damage and cell cycle arrest. J Pharmacol Sci 98, 16–24.
114 SC Shen , WR Lee , HY Lin , HC Huang , CH Ko , LL Yang & YC Chen (2002) In vitro and in vivo inhibitory activities of rutin, wogonin, and quercetin on lipopolysaccharide-induced nitric oxide and prostaglandin E(2) production. Eur J Pharmacol 446, 187–194.
115 KJ Woo , JH Lim , SI Suh , YK Kwon , SW Shin , SC Kim , YH Choi , JW Park & TK Kwon (2006) Differential inhibitory effects of baicalein and baicalin on LPS-induced cyclooxygenase-2 expression through inhibition of C/EBPbeta DNA-binding activity. Immunobiology 211, 359–368.
116 H Kim , YS Kim , SY Kim & K Suk (2001) The plant flavonoid wogonin suppresses death of activated C6 rat glial cells by inhibiting nitric oxide production. Neurosci Lett 309, 67–71.
117 CJ Chen , SL Raung , SL Liao & SY Chen (2004) Inhibition of inducible nitric oxide synthase expression by baicalein in endotoxin/cytokine-stimulated microglia. Biochem Pharmacol 67, 957–965.
118 JC Chen , FM Ho , LC Pei-Dawn , CP Chen , KC Jeng , HB Hsu , ST Lee , TW Wen & WW Lin (2005) Inhibition of iNOS gene expression by quercetin is mediated by the inhibition of IkappaB kinase, nuclear factor-kappa B and STAT1, and depends on heme oxygenase-1 induction in mouse BV-2 microglia. Eur J Pharmacol 521, 9–20.
119 WF Matter , RF Brown & CJ Vlahos (1992) The inhibition of phosphatidylinositol 3-kinase by quercetin and analogs. Biochem Biophys Res Commun 186, 624–631.
121 G Agullo , L Gamet-Payrastre , S Manenti , C Viala , C Remesy , H Chap & B Payrastre (1997) Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition. Biochem Pharmacol 53, 1649–1657.
122 L Gamet-Payrastre , S Manenti , MP Gratacap , J Tulliez , H Chap & B Payrastre (1999) Flavonoids and the inhibition of PKC and PI 3-kinase. Gen Pharmacol 32, 279–286.
123 AN Kong , R Yu , C Chen , S Mandlekar & T Primiano (2000) Signal transduction events elicited by natural products: role of MAPK and caspase pathways in homeostatic response and induction of apoptosis. Arch Pharm Res 23, 1–16.
124 CH Lin , SH Yeh , CH Lin , KT Lu , TH Leu , WC Chang & PW Gean (2001) A role for the PI-3 kinase signaling pathway in fear conditioning and synaptic plasticity in the amygdala. Neuron 31, 841–851.
125 JD Sweatt (2001) Memory mechanisms: the yin and yang of protein phosphorylation. Curr Biol 11, R391–R394.
126 G Conseil , H Baubichon-Cortay , G Dayan , JM Jault , D Barron & A Di Pietro (1998) Flavonoids: a class of modulators with bifunctional interactions at vicinal ATP- and steroid-binding sites on mouse P-glycoprotein. Proc Natl Acad Sci U S A 95, 9831–9836.
127 A Di Pietro , C Godinot , ML Bouillant & DC Gautheron (1975) Pig heart mitochondrial ATPase: properties of purified and membrane-bound enzyme. Effects of flavonoids. Biochimie 57, 959–967.
128 A Barzilai & H Rahamimoff (1983) Inhibition of Ca2+-transport ATPase from synaptosomal vesicles by flavonoids. Biochim Biophys Acta 730, 245–254.
129 MP Revuelta , B Cantabrana & A Hidalgo (1997) Depolarization-dependent effect of flavonoids in rat uterine smooth muscle contraction elicited by CaCl2. Gen Pharmacol 29, 847–857.
130 SF Lee & JK Lin (1997) Inhibitory effects of phytopolyphenols on TPA-induced transformation, PKC activation, and c-jun expression in mouse fibroblast cells. Nutr Cancer 28, 177–183.
131 F Ursini , M Maiorino , P Morazzoni , A Roveri & G Pifferi (1994) A novel antioxidant flavonoid (IdB 1031) affecting molecular mechanisms of cellular activation. Free Radic Biol Med 16, 547–553.
132 S Kantengwa & BS Polla (1991) Flavonoids, but not protein kinase C inhibitors, prevent stress protein synthesis during erythrophagocytosis. Biochem Biophys Res Commun 180, 308–314.
133 M Rosenblat , P Belinky , J Vaya , R Levy , T Hayek , R Coleman , S Merchav & M Aviram (1999) Macrophage enrichment with the isoflavan glabridin inhibits NADPH oxidase-induced cell-mediated oxidation of low density lipoprotein. A possible role for protein kinase C. J Biol Chem 274, 13790–13799.
135 JH Medina , H Viola , C Wolfman , M Marder , C Wasowski , D Calvo & AC Paladini (1997) Overview—flavonoids: a new family of benzodiazepine receptor ligands. Neurochem Res 22, 419–425.
136 K Dekermendjian , P Kahnberg , MR Witt , O Sterner , M Nielsen & T Liljefors (1999) Structure–activity relationships and molecular modeling analysis of flavonoids binding to the benzodiazepine site of the rat brain GABA(A) receptor complex. J Med Chem 42, 4343–4350.
137 PM Fischer & DP Lane (2000) Inhibitors of cyclin-dependent kinases as anti-cancer therapeutics. Curr Med Chem 7, 1213–1245.
138 YT Huang , JJ Hwang , PP Lee , FC Ke , JH Huang , CJ Huang , C Kandaswami , E Middleton Jr & MT Lee (1999) Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor. Br J Pharmacol 128, 999–1010.
139 FV So , N Guthrie , AF Chambers , M Moussa & KK Carroll (1996) Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices. Nutr Cancer 26, 167–181.
140 DR Green & JC Reed (1998) Mitochondria and apoptosis. Science 281, 1309–1312.
141 WG Tatton & CW Olanow (1999) Apoptosis in neurodegenerative diseases: the role of mitochondria. Biochim Biophys Acta 1410, 195–213.
142 L Goyal (2001) Cell death inhibition: keeping caspases in check. Cell 104, 805–808.
143 SM Srinivasula , R Hegde , A Saleh , (2001) A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis. Nature 410, 112–116.
144 MH Cobb & EJ Goldsmith (1995) How MAP kinases are regulated. J Biol Chem 270, 14843–14846.
145 EJ Goldsmith & MH Cobb (1994) Protein kinases. Curr Opin Struct Biol 4, 833–840.
146 CJ Marshall (1994) Signal transduction. Hot lips and phosphorylation of protein kinases. Nature 367, 686.
147 M Karin (1995) The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 270, 16483–16486.
148 Z Xia , M Dickens , J Raingeaud , RJ Davis & ME Greenberg (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270, 1326–1331.
150 A Bonni , A Brunet , AE West , SR Datta , MA Takasu & ME Greenberg (1999) Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 286, 1358–1362.
151 DR Kaplan & FD Miller (2000) Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol 10, 381–391.
152 AJ Crossthwaite , S Hasan & RJ Williams (2002) Hydrogen peroxide-mediated phosphorylation of ERK1/2, Akt/PKB and JNK in cortical neurones: dependence on Ca(2+) and PI3-kinase. J Neurochem 80, 24–35.
153 K Mielke & T Herdegen (2000) JNK and p38 stresskinases—degenerative effectors of signal-transduction-cascades in the nervous system. Prog Neurobiol 61, 45–60.
154 J Yuan & BA Yankner (2000) Apoptosis in the nervous system. Nature 407, 802–809.
156 RJ Davis (2000) Signal transduction by the JNK group of MAP kinases. Cell 103, 239–252.
158 T Herdegen , P Skene & M Bahr (1997) The c-Jun transcription factor—bipotential mediator of neuronal death, survival and regeneration. Trends Neurosci 20, 227–231.
159 V Castagne & PG Clarke (1999) Inhibitors of mitogen-activated protein kinases protect axotomized developing neurons. Brain Res 842, 215–219.
160 V Castagne , M Gautschi , K Lefevre , A Posada & PG Clarke (1999) Relationships between neuronal death and the cellular redox status. Focus on the developing nervous system. Prog Neurobiol 59, 397–423.
161 SP Hung , JR Hsu , CP Lo , HJ Huang , JP Wang & ST Chen (2005) Genistein-induced neuronal differentiation is associated with activation of extracellular signal-regulated kinases and upregulation of p21 and N-cadherin. J Cell Biochem 96, 1061–1070.
162 F Llorens , L Garcia , E Itarte & N Gomez (2002) Apigenin and LY294002 prolong EGF-stimulated ERK1/2 activation in PC12 cells but are unable to induce full differentiation. FEBS Lett 510, 149–153.
163 DT Dudley , L Pang , SJ Decker , AJ Bridges & AR Saltiel (1995) A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci U S A 92, 7686–7689.
164 L Pang , T Sawada , SJ Decker & AR Saltiel (1995) Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J Biol Chem 270, 13585–13588.
166 DF Lazar , RJ Wiese , MJ Brady , CC Mastick , SB Waters , K Yamauchi , JE Pessin , P Cuatrecasas & AR Saltiel (1995) Mitogen-activated protein kinase kinase inhibition does not block the stimulation of glucose utilization by insulin. J Biol Chem 270, 20801–20807.
167 Y Levites , T Amit , MB Youdim & S Mandel (2002) Involvement of protein kinase C activation and cell survival/cell cycle genes in green tea polyphenol ( − )-epigallocatechin 3-gallate neuroprotective action. J Biol Chem 277, 30574–30580.
168 L Reznichenko , T Amit , MB Youdim & S Mandel (2005) Green tea polyphenol ( − )-epigallocatechin-3-gallate induces neurorescue of long-term serum-deprived PC12 cells and promotes neurite outgrowth. J Neurochem 93, 1157–1167.
169 EH Walker , ME Pacold , O Perisic , L Stephens , PT Hawkins , MP Wymann & RL Williams (2000) Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol Cell 6, 909–919.
171 KA Jacobson , S Moro , JA Manthey , PL West & XD Ji (2002) Interactions of flavones and other phytochemicals with adenosine receptors. Adv Exp Med Biol 505, 163–171.
172 GA Johnston (2005) GABA(A) receptor channel pharmacology. Curr Pharm Des 11, 1867–1885.
173 N Adachi , S Tomonaga , T Tachibana , DM Denbow & M Furuse (2006) ( − )-Epigallocatechin gallate attenuates acute stress responses through GABAergic system in the brain. Eur J Pharmacol 531, 171–175.
174 YS Han , S Bastianetto , Y Dumont & R Quirion (2006) Specific plasma membrane binding sites for polyphenols, including resveratrol, in the rat brain. J Pharmacol Exp Ther 318, 238–245.
175 AP Nifli , A Bosson-Kouame , N Papadopoulou , C Kogia , M Kampa , C Castagnino , C Stournaras , J Vercauteren & E Castanas (2005) Monomeric and oligomeric flavanols are agonists of membrane androgen receptors. Exp Cell Res 309, 329–339.
176 CM Klinge , KA Blankenship , KE Risinger , S Bhatnagar , EL Noisin , WK Sumanasekera , L Zhao , DM Brey & RS Keynton (2005) Resveratrol and estradiol rapidly activate MAPK signaling through estrogen receptors alpha and beta in endothelial cells. J Biol Chem 280, 7460–7468.
178 Y Kim , AE Rice & JM Denu (2003) Intramolecular dephosphorylation of ERK by MKP3. Biochemistry 42, 15197–15207.
180 S Leppa & D Bohmann (1999) Diverse functions of JNK signaling and c-Jun in stress response and apoptosis. Oncogene 18, 6158–6162.
181 H Ichijo (1999) . In Oncogene 18, pp. 6087–6093.
182 H Ichijo , E Nishida , K Irie , P ten Dijke , M Saitoh , T Moriguchi , M Takagi , K Matsumoto , K Miyazono & Y Gotoh (1997) Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275, 90–94.
184 A Matsuzawa & H Ichijo (2001) Molecular mechanisms of the decision between life and death: regulation of apoptosis by apoptosis signal-regulating kinase 1. J Biochem (Tokyo) 130, 1–8.
185 H Schroeter , RJ Williams , R Matin , L Iversen & CA Rice-Evans (2000) Phenolic antioxidants attenuate neuronal cell death following uptake of oxidized low-density lipoprotein. Free Radic Biol Med 29, 1222–1233.
186 JPE Spencer , H Schroeter , G Kuhnle , SK Srai , RM Tyrrell , U Hahn & C Rice-Evans (2001) Epicatechin and its in vivo metabolite, 3′-O-methyl epicatechin, protect human fibroblasts from oxidative-stress-induced cell death involving caspase-3 activation. Biochem J 354, 493–500.
187 L Wang , K Matsushita , I Araki & M Takeda (2002) Inhibition of c-Jun N-terminal kinase ameliorates apoptosis induced by hydrogen peroxide in the kidney tubule epithelial cells (NRK-52E). Nephron 91, 142–147.
188 Y Ishikawa & M Kitamura (2000) Anti-apoptotic effect of quercetin: intervention in the JNK- and ERK-mediated apoptotic pathways. Kidney Int 58, 1078–1087.
189 K Uchida , M Shiraishi , Y Naito , Y Torii , Y Nakamura & T Osawa (1999) Activation of stress signaling pathways by the end product of lipid peroxidation. 4-Hydroxy-2-nonenal is a potential inducer of intracellular peroxide production. J Biol Chem 274, 2234–2242.
190 L Zhang , J Chen & H Fu (1999) Suppression of apoptosis signal-regulating kinase 1-induced cell death by 14-3-3 proteins. Proc Natl Acad Sci U S A 96, 8511–8515.
191 HS Park , E Park , MS Kim , K Ahn , IY Kim & EJ Choi (2000) Selenite inhibits the c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) through a thiol redox mechanism. J Biol Chem 275, 2527–2531.
192 V Adler , Z Yin , SY Fuchs , (1999) Regulation of JNK signaling by GSTp. EMBO J 18, 1321–1334.
193 V Adler , Z Yin , KD Tew & Z Ronai (1999) Role of redox potential and reactive oxygen species in stress signaling. Oncogene 18, 6104–6111.
194 R Monaco , FK Friedman , MJ Hyde , JM Chen , S Manolatus , V Adler , Z Ronai , W Koslosky & MR Pincus (1999) Identification of a glutathione-S-transferase effector domain for inhibition of jun kinase, by molecular dynamics. J Protein Chem 18, 859–866.
196 JPE Spencer , El Abd , MM Mohsen & C Rice-Evans (2003) Cellular uptake and metabolism of flavonoids and their metabolites: implications for their bioactivity. Arch Biochem Biophys 423, 148–161.
197 SG Kennedy , AJ Wagner , SD Conzen , J Jordan , A Bellacosa , PN Tsichlis & N Hay (1997) The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev 11, 701–713.
198 PJ Coffer , J Jin & JR Woodgett (1998) Protein kinase B (c-Akt): a multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem J 335, [Pt 1], 1–13.
199 FD Miller & DR Kaplan (2001) Neurotrophin signalling pathways regulating neuronal apoptosis. Cell Mol Life Sci 58, 1045–1053.
201 CL Carpenter & LC Cantley (1990) Phosphoinositide kinases. Biochemistry 29, 11147–11156.
202 L Simpson & R Parsons (2001) PTEN: life as a tumor suppressor. Exp Cell Res 264, 29–41.
203 LM Neri , P Borgatti , S Capitani & AM Martelli (2002) The nuclear phosphoinositide 3-kinase/AKT pathway: a new second messenger system. Biochim Biophys Acta 1584, 73–80.
204 TF Franke , DR Kaplan & LC Cantley (1997) PI3K: downstream AKTion blocks apoptosis. Cell 88, 435–437.
205 BM Burgering & PJ Coffer (1995) Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376, 599–602.
206 TF Franke , SI Yang , TO Chan , K Datta , A Kazlauskas , DK Morrison , DR Kaplan & PN Tsichlis (1995) The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81, 727–736.
207 MH Cardone , N Roy , HR Stennicke , GS Salvesen , TF Franke , E Stanbridge , S Frisch & JC Reed (1998) Regulation of cell death protease caspase-9 by phosphorylation. Science 282, 1318–1321.
208 BM Burgering & GJ Kops (2002) Cell cycle and death control: long live Forkheads. Trends Biochem Sci 27, 352–360.
209 A Brunet , A Bonni , MJ Zigmond , MZ Lin , P Juo , LS Hu , MJ Anderson , KC Arden , J Blenis & ME Greenberg (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96, 857–868.
210 J Zha , H Harada , E Yang , J Jockel & SJ Korsmeyer (1996) Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 87, 619–628.
212 SR Datta , H Dudek , X Tao , S Masters , H Fu , Y Gotoh & ME Greenberg (1997) Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91, 231–241.
213 L del Peso , M Gonzalez-Garcia , C Page , R Herrera & G Nunez (1997) Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278, 687–689.
214 PC Ferriola , V Cody & E Middleton Jr (1989) Protein kinase C inhibition by plant flavonoids. Kinetic mechanisms and structure–activity relationships. Biochem Pharmacol 38, 1617–1624.
217 B Dave , RR Eason , SR Till , Y Geng , MC Velarde , TM Badger & RC Simmen (2005) The soy isoflavone genistein promotes apoptosis in mammary epithelial cells by inducing the tumor suppressor PTEN. Carcinogenesis 26, 1793–1803.
218 LC Cantley & BG Neel (1999) New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci U S A 96, 4240–4245.
219 MP Myers , I Pass , IH Batty , KJ Van der KJ , JP Stolarov , BA Hemmings , MH Wigler , CP Downes & NK Tonks (1998) The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc Natl Acad Sci U S A 95, 13513–13518.
220 X Wu , K Senechal , MS Neshat , YE Whang & CL Sawyers (1998) The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway. Proc Natl Acad Sci U S A 95, 15587–15591.
221 AC Wild , HR Moinova & RT Mulcahy (1999) Regulation of gamma-glutamylcysteine synthetase subunit gene expression by the transcription factor Nrf2. J Biol Chem 274, 33627–33636.
222 HR Moinova & RT Mulcahy (1999) Up-regulation of the human gamma-glutamylcysteine synthetase regulatory subunit gene involves binding of Nrf-2 to an electrophile responsive element. Biochem Biophys Res Commun 261, 661–668.
223 R Venugopal & AK Jaiswal (1998) Nrf2 and Nrf1 in association with Jun proteins regulate antioxidant response element-mediated expression and coordinated induction of genes encoding detoxifying enzymes. Oncogene 17, 3145–3156.
224 R Venugopal & AK Jaiswal (1996) Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene. Proc Natl Acad Sci U S A 93, 14960–14965.
225 KW Kang , SJ Lee & SG Kim (2005) Molecular mechanism of nrf2 activation by oxidative stress. Antioxid Redox Signal 7, 1664–1673.
226 K Itoh , KI Tong & M Yamamoto (2004) Molecular mechanism activating Nrf2-Keap1 pathway in regulation of adaptive response to electrophiles. Free Radic Biol Med 36, 1208–1213.
227 L Leung , M Kwong , S Hou , C Lee & JY Chan (2003) Deficiency of the Nrf1 and Nrf2 transcription factors results in early embryonic lethality and severe oxidative stress. J Biol Chem 278, 48021–48029.
228 D Bloom , S Dhakshinamoorthy & AK Jaiswal (2002) Site-directed mutagenesis of cysteine to serine in the DNA binding region of Nrf2 decreases its capacity to upregulate antioxidant response element-mediated expression and antioxidant induction of NAD(P)H:quinone oxidoreductase1 gene. Oncogene 21, 2191–2200.
230 A Banning , S Deubel , D Kluth , Z Zhou & R Brigelius-Flohe (2005) The GI-GPx gene is a target for Nrf2. Mol Cell Biol 25, 4914–4923.
231 E Hernandez-Montes , SE Pollard , D Vauzour , L Jofre-Montseny , C Rota , G Rimbach , PD Weinberg & JP Spencer (2006) Activation of glutathione peroxidase via Nrf1 mediates genistein's protection against oxidative endothelial cell injury. Biochem Biophys Res Commun 346, 851–859.
232 K Itoh , N Wakabayashi , Y Katoh , T Ishii , K Igarashi , JD Engel & M Yamamoto (1999) Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev 13, 76–86.
233 JD Hayes & M McMahon (2001) Molecular basis for the contribution of the antioxidant responsive element to cancer chemoprevention. Cancer Lett 174, 103–113.
234 MJ Alcaraz , AM Vicente , A Araico , JN Dominguez , MC Terencio & ML Ferrandiz (2004) Role of nuclear factor-kappaB and heme oxygenase-1 in the mechanism of action of an anti-inflammatory chalcone derivative in RAW 264.7 cells. Br J Pharmacol 142, 1191–1199.
235 M Kobayashi & M Yamamoto (2005) Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation. Antioxid Redox Signal 7, 385–394.
236 T Nguyen , PJ Sherratt , HC Huang , CS Yang & CB Pickett (2003) Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element. Degradation of Nrf2 by the 26 S proteasome. J Biol Chem 278, 4536–4541.
237 T Nguyen , HC Huang & CB Pickett (2000) Transcriptional regulation of the antioxidant response element. Activation by Nrf2 and repression by MafK. J Biol Chem 275, 15466–15473.
238 PJ Sherratt , HC Huang , T Nguyen & CB Pickett (2004) Role of protein phosphorylation in the regulation of NF-E2-related factor 2 activity. Methods Enzymol 378, 286–301.
239 R Yu , S Mandlekar , W Lei , WE Fahl , TH Tan & AN Kong (2000) p38 mitogen-activated protein kinase negatively regulates the induction of phase II drug-metabolizing enzymes that detoxify carcinogens. J Biol Chem 275, 2322–2327.
240 G Shen , V Hebbar , S Nair , C Xu , W Li , W Lin , YS Keum , J Han , MA Gallo & AN Kong (2004) Regulation of Nrf2 transactivation domain activity. The differential effects of mitogen-activated protein kinase cascades and synergistic stimulatory effect of Raf and CREB-binding protein. J Biol Chem 279, 23052–23060.
241 KW Kang , SJ Lee , JW Park & SG Kim (2002) Phosphatidylinositol 3-kinase regulates nuclear translocation of NF-E2-related factor 2 through actin rearrangement in response to oxidative stress. Mol Pharmacol 62, 1001–1010.
242 K Nakaso , H Yano , Y Fukuhara , T Takeshima , K Wada-Isoe & K Nakashima (2003) PI3K is a key molecule in the Nrf2-mediated regulation of antioxidative proteins by hemin in human neuroblastoma cells. FEBS Lett 546, 181–184.